Full Name
Sam O. Kleeman
Speaker Bio
Sam Kleeman’s photo attached and bio below for the Oral Abstract presenter on Friday afternoon. Disclosure completed.
Dr. Kleeman earned his undergraduate degree from the University of Cambridge, UK and an MD from the University of Oxford, UK. Subsequently, he completed a two-year internal medicine internship in the UK’s National Health Service. He recently completed his PhD at Cold Spring Harbor Laboratory (CSHL) under the joint mentorship of Dr. Tobias Janowitz and Dr. Hiro Furukawa. His PhD thesis leveraged anti-NMDA receptor encephalitis as a paradigm for the connectivity between anti-cancer immunity and autoimmunity, integrating methodologies from the fields of neuroscience, tumor immunology and structural biology. Currently a postdoctoral fellow at CSHL, Dr. Kleeman is focused on translating his research findings into novel treatments for NMDA receptor-positive tumors, including triple-negative breast cancer. Dr. Kleeman hopes to pursue a career as a physician-scientist oncologist.
Dr. Kleeman earned his undergraduate degree from the University of Cambridge, UK and an MD from the University of Oxford, UK. Subsequently, he completed a two-year internal medicine internship in the UK’s National Health Service. He recently completed his PhD at Cold Spring Harbor Laboratory (CSHL) under the joint mentorship of Dr. Tobias Janowitz and Dr. Hiro Furukawa. His PhD thesis leveraged anti-NMDA receptor encephalitis as a paradigm for the connectivity between anti-cancer immunity and autoimmunity, integrating methodologies from the fields of neuroscience, tumor immunology and structural biology. Currently a postdoctoral fellow at CSHL, Dr. Kleeman is focused on translating his research findings into novel treatments for NMDA receptor-positive tumors, including triple-negative breast cancer. Dr. Kleeman hopes to pursue a career as a physician-scientist oncologist.
